Shaily Engineering Plastics Ltd

Shaily Engineering Plastics Limited will hold a board meeting on August 8, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and will publish those results in Crores instead of Lacs, the company said in a filing. The company also closed its trading window for insiders from July 1, 2026, until August 10, 2026, in accordance with SEBI regulations.

Shaily Engineering Plastics announced that its strategic partner Orbicular Pharmaceutical Technologies in partnership with its Customer has launched a generic version of Semaglutide injection in Canada, incorporating Shaily's proprietary spring-driven ShailyPen Neo' pen platform. The combination product has been commercially available in India since March 2026 and has received USFDA Tentative Approval. ShailyPen Neo' is among a rare class of commercially available spring-driven pen injectors globally ' a high-performance, variable and fixed dose platform offering full compatibility with ISO-standard 3 mL cartridges (3 mL and 1.5 mL fill). Shaily's role in this program relates to full design and development, and manufacturing and supply of the device components used in the approved combination product.

Shaily Engineering Plastics has allotted 40,155 equity shares under ESOP on 19 May 2026. With this allotment, the paid up equity share capital has increased to Rs. 9,19,90,496 divided into 4,59,95,248 equity shares of Rs. 2/- each.

Shaily Engineering Plastics announced that the Board of Directors of the Company at its meeting held on 19 May 2026, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 150%) , subject to the approval of the shareholders.

Net profit of Shaily Engineering Plastics rose 40.47% to Rs 40.16 crore in the quarter ended March 2026 as against Rs 28.59 crore during the previous quarter ended March 2025. Sales rose 8.72% to Rs 236.82 crore in the quarter ended March 2026 as against Rs 217.83 crore during the previous quarter ended March 2025. For the full year,net profit rose 82.46% to Rs 169.91 crore in the year ended March 2026 as against Rs 93.12 crore during the previous year ended March 2025. Sales rose 25.91% to Rs 990.67 crore in the year ended March 2026 as against Rs 786.80 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales236.82217.83 9 990.67786.80 26 OPM %27.7125.02 -28.2622.38 - PBDT65.5950.71 29 271.83161.43 68 PBT52.3239.60 32 222.61119.28 87 NP40.1628.59 40 169.9193.12 82 Powered by Capital Market - Live

Net profit of Shaily Engineering Plastics rose 64.85% to Rs 48.68 crore in the quarter ended March 2026 as against Rs 29.53 crore during the previous quarter ended March 2025. Sales rose 10.23% to Rs 224.07 crore in the quarter ended March 2026 as against Rs 203.28 crore during the previous quarter ended March 2025. For the full year,net profit rose 127.50% to Rs 161.32 crore in the year ended March 2026 as against Rs 70.91 crore during the previous year ended March 2025. Sales rose 24.80% to Rs 921.20 crore in the year ended March 2026 as against Rs 738.12 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales224.07203.28 10 921.20738.12 25 OPM %28.0423.54 -27.7019.45 - PBDT72.8748.48 50 257.23134.08 92 PBT60.9438.13 60 211.8694.66 124 NP48.6829.53 65 161.3270.91 127 Powered by Capital Market - Live

Shaily Engineering Plastics will hold a meeting of the Board of Directors of the Company on 19 May 2026.

According to bulk deal data, the fund purchased 2.98 lakh shares on the NSE at Rs 1,878.41 per share and another 6.43 lakh shares on the BSE at Rs 1,879 per share, aggregating to a 2.05% stake valued at about Rs 176.88 crore. As of December 2025, Smallcap World Fund Inc. already held a 5.09% equity stake, or 23,38,792 shares, in Shaily Engineering Plastics, a company backed by investor Ashish Kacholia. Smallcap World Fund Inc. is a US-based mutual fund managed by Capital Group. Shaily Engineering Plastics is engaged in the manufacture and sale of injection-molded precision plastic components and sub-assemblies for various requirements of Original Equipment Manufacturers (OEM). The company's consolidated net profit jumped 48.3% to Rs 37.38 crore on a 26.8% rise in revenue from operations to Rs 250.50 crore in Q3 FY26 over Q3 FY25. Powered by Capital Market - Live

The customer's name has not been disclosed due to confidentiality reasons, stated the exchange filing. The order has been awarded by a domestic entity and involves the manufacturing and commercial supply of pen injectors over a period of four years. The company clarified in the filing that neither the promoter nor the promoter group has any interest in the awarding entity. It also stated that the contract does not fall under related party transactions. Shaily Engineering Plastics is engaged in the manufacture and sale of injection-molded precision plastic components and sub-assemblies for various requirements of Original Equipment Manufacturers (OEM). The company's consolidated net profit jumped 48.3% to Rs 37.38 crore on a 26.8% rise in revenue from operations to Rs 250.50 crore in Q3 FY26 over Q3 FY25.Powered by Capital Market - Live

Shaily Engineering Plastics has received an order worth Rs 423 crore for supply of pen injectors over a period of four years. The order is placed by a large domestic pharma company. Powered by Capital Market - Live